Celon Pharma's Generic Semaglutide Reduzek Matches Ozempic, Wegovy in Bioequivalence Study Written By sheeba farhat22 Aug 2026 9:00 PM ISTGdansk: Celon Pharma's experimental semaglutide product Reduzek, a generic alternative to Novo Nordisk's Wegovy and Ozempic, matched the blockbuster...
Eli Lilly Sues 6 Firms Over Alleged Black-Market Sale of Unapproved Obesity Drug Retatrutide Written By MD Bureau13 Aug 2026 11:15 AM ISTNew Delhi: Eli Lilly on Wednesday said it had filed six lawsuits against U.S. companies it accuses of illegally selling black-market versions of its...
US Judge Partly Refuses to Dismiss Investor Fraud Suit Against Novo Nordisk Over CagriSema Written By sheeba farhat29 July 2026 10:08 PM ISTNew York: A U.S. judge said on Tuesday that Novo Nordisk must face part of a lawsuit accusing it of defrauding shareholders about a clinical trial for...
Novo Nordisk to Launch Lower-Cost Ozempic Copy Extensior in South Africa Written By sheeba farhat18 July 2026 4:39 PM ISTJohannesburg: Novo Nordisk will launch a more affordable authorised copy of its Ozempic diabetes drug in South Africa later this month, partnering...
EMA Backs Novo Nordisk's Oral Wegovy, Paving Way for Europe's First Weight-Loss Pill Written By sheeba farhat25 May 2026 10:30 AM ISTLondon: The European Medicines Agency recommended approval of Novo Nordisk's pill Wegovy, the regulator said on Friday, clearing the way for it to...
Generic Semaglutide Therapy Cost in India May Drop to Rs 500 a Month: Report Written By Parthika Patel15 May 2026 10:46 PM ISTNew Delhi: Prices of generic semaglutide, the popular weight-loss and anti-diabetes drug, are expected to decline sharply in India over the next six...
Setback to Wave Life Sciences: Obesity Drug WVE-007 Shows Limited Efficacy in Early Trial Written By sheeba farhat27 March 2026 11:05 PM ISTBengaluru: Wave Life Sciences shares plunged 58% on Thursday after a higher dose of its experimental obesity drug failed to show a clear improvement...
USFDA Approves Higher-Dose Wegovy to Boost Weight Loss Outcomes Written By sheeba farhat21 March 2026 11:00 AM ISTWashington: Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more...
Novo Nordisk's Wegovy Gets UK Nod for Higher 7.2 mg Weekly Dose in Obesity Treatment Written By sheeba farhat17 Jan 2026 4:06 PM ISTThe authorisation for the drug, chemically known as semaglutide, covers only patients with a body mass index of 30 or higher using the drug for weight...
Natco Pharma Challenges Novo Nordisk's Wegovy Patent, Reaches Delhi High Court Written By Susmita Roy7 Jan 2026 11:19 PM ISTNew Delhi: Hyderabad-based Natco Pharma has approached the Delhi High Court with a petition seeking revocation of a patent held by Novo Nordisk, the...
Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boom Written By Ruchika Sharma22 Nov 2025 5:49 PM ISTBengaluru: Eli Lilly just hit a USD 1 trillion in market value, becoming the first-ever pharmaceutical company to join the exclusive...
Eli Lilly's Diabetes Drug Mounjaro Gets Second Brand Yurpeak via Cipla Deal Written By Farhat Nasim24 Oct 2025 11:36 AM ISTNew Delhi: In a move aimed at expanding access to obesity and diabetes care in India, Eli Lilly and Company (India) Pvt. Ltd. (Lilly) and Cipla...
